ALX Oncology Holdings Inc.
ALXO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $22 | $33 | $88 |
| - Cash | $23 | $19 | $21 | $18 |
| + Debt | $0 | $16 | $10 | $10 |
| Enterprise Value | – | $19 | $23 | $81 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$25 | -$30 | -$29 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$26 | -$31 | -$29 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.49 | -0.58 | -0.55 |
| % Growth | 16.3% | 15.5% | -5.5% | – |
| Operating Cash Flow | -$17 | -$23 | -$25 | -$32 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$17 | -$23 | -$25 | -$32 |